Pharmacogenetic Determinants for Discontinuation of Non-Ergoline Dopamine Agonists in Parkinson's Disease

Translated title of the contribution: Pharmacogenetic Determinants for Discontinuation of Non-Ergoline Dopamine Agonists in Parkinson's Disease

M.E.L. Arbouw, K.L.L. Movig, A.C.G. Egberts, P.J.E. Poels, J.P.P. van Vugt, J.G.H. Wessels, T.R.J.H.M. van der Straaten, C. Neef, H.J. Guchelaar

Research output: Contribution to journalMeeting AbstractOther research output

Translated title of the contributionPharmacogenetic Determinants for Discontinuation of Non-Ergoline Dopamine Agonists in Parkinson's Disease
Original languageUndefined/Unknown
Pages (from-to)S163
Number of pages1
JournalPharmacoepidemiology and Drug Safety
Volume18
Publication statusPublished - 2009

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this